Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	40.56	-138.27	-232.64
Graham Fair Price	2.72	9.64	9.38
PEG	-51.46	0.62	-1.28
Price/Book	-9.91	14.26	15.83
Price/Cash Flow	-69.30	61.76	201.19
Prices/Earnings	32.36	-12.03	-17.79
Price/Sales	-21.73	18.62	23.79
Price/FCF	-69.30	61.76	201.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-1.48	0.60	0.61
Operating Margin	-18.13	-0.36	-0.30
ROA	-19.21	-0.03	-0.02
ROE	-0.22	-0.30	-33.19
ROIC	-0.03	-0.04	-21.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	< 0.005	-103.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.11	-0.22	101.93
EPS QOQ	0.14	-0.19	39.35
FCF QOQ	-0.45	1.62	258.82
Revenue QOQ	0.08	0.03	-60.64
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	379.56	337.30	-11.13
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.87	0.89	1.34
Quick Ratio	1.72	1.69	-1.40
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	4.19	3.73	-10.99
Cash	10.70	11.31	5.76
Capex	-0.05	-0.08	-38.95
Free Cash Flow	0.33	0.86	161.21
Revenue	2.79	2.86	2.45
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.82	1.78	-1.90
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-58.08	-40.50	30.28
Naive Interpretation	Member

06 - Financial Health · Weak

Rating